Patients with double primary tumors in the breast and ovary - Clinical characteristics and BRCA1-2 mutations status

Gynecologic Oncology

Volumn 79, Issue 1, 2000, Pages 74-78

  Fishman, Ami ^a   Dekel, Eyal ^a   Chetrit, Angela ^b   Lerner Geva, Liat ^b   Bar Am, Amiram ^c   Beck, Dan ^d   Beller, Uziel ^e   Ben Baruch, Gilad ^b   Piura, Benjamin ^f   Friedman, Eitan ^b   Struewing, Jeffery P ^g   Modan, Baruch ^b  

^a MEIR MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e SHAARE ZEDEK MEDICAL CENTER   (Israel)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

BRCA1 2 mutations; Breast cancer; Double primary malignancy; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN;

ADULT; ADVANCED CANCER; ARTICLE; BREAST TUMOR; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; DISEASE ASSOCIATION; FAMILIAL CANCER; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; OVARY TUMOR; PREVALENCE; PRIORITY JOURNAL;

EID: 0033769823     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5895     Document Type: Article

References (35)

1. Second primary neoplasms following ovarian cancer
2. Multiple primary cancers of the breast and ovary
3. Second cancer following cancer of the female genital system in Connecticut
4. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries
5. Multiple primary cancer of the breast, endometrium and ovary
6. Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies within a cancer registry
7. Second malignant neoplasms among long-term survivors of ovarian cancer
8. Second primary cancers in a cohort of Israeli women with primary gynecologic malignancies
9. Population genetics of BRCA1 and BRCA2
10. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
11. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families
12. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals
13. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
14. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women
15. Hereditary ovarian cancer: Molecular genetics and clinical implications
16. Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors
17. Hereditary ovarian cancer: A clinicopathological study
18. Contribution of BRCA1 mutations to ovarian cancer
19. Histology of BRCA1-associated ovarian tumors
20. Familial ovarian cancer: A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991
21. Age at diagnosis and multiple primary cancers of the breast and ovary
22. Ovarian disease in women with breast cancer
23. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history
24. Sequence analysis of BRCA1 and BRCA2: Correlation of mutation with family history and ovarian cancer risk
25. Risks of cancer in BRCA1 mutation carriers. Breast cancer linkage consortium
26. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer
27. Germline BRCA1 185delAG mutations in Jewish women with breast cancer
28. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
29. High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel
30. Founder recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families
31. BRCA-associated breast cancer in young women
32. P53 mutations in BRCA1-associated familial breast cancer
33. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers
34. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumors
35. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations